Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Other Non-Current Assets (2009 - 2026)

Updated

Bristol Myers Squibb's Other Assets was $6.1 billion in Q3 2026, down 3.7% from $6.33 billion a year earlier and down 4.4% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Other Non-Current Assets (2009 - 2026) Analysis & Trends

At the end of FY2025, Other Assets at Bristol Myers Squibb came in at $6.47 billion, up 6.0% from FY2024.

  • Other Assets has now increased for three consecutive years, though with a five-year compound annual growth rate of -1.6% (FY2020 to FY2025).
  • In earlier years, Other Assets was $6.11 billion in FY2024 (+13.7%), $5.37 billion in FY2023 (+8.7%), $4.94 billion in FY2022 (-10.7%) and $5.54 billion in FY2021 (-21.1%).
  • Quarterly Other Assets has moved between $53 million (Q1 2023) and $6.47 billion (Q4 2025) over five years.
  • Compared with a year earlier, Other Assets was higher in five of the last eight quarters, with growth averaging 3.4%.
  • The best year-over-year quarter for Other Assets over five years was Q4 2024 (growth of 13.7%); the worst was Q1 2022 (a decline of 97.1%).
  • Per Business Quant data, BMY's Other Assets in the three quarters before Q3 2026 was $6.38 billion (Q2 2026), $6.08 billion (Q1 2026) and $6.47 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 7.70 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 15.10 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 9.42 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 19.90 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - 700.00 Mn
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 14.60 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 4.90 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 10.02 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 6.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.10 Bn
Jun 30, 2026 6.38 Bn
Mar 31, 2026 6.08 Bn
Dec 31, 2025 6.47 Bn
Sep 30, 2025 6.33 Bn
Jun 30, 2025 5.94 Bn
Mar 31, 2025 5.87 Bn
Dec 31, 2024 6.11 Bn
Sep 30, 2024 6.04 Bn
Jun 30, 2024 6.07 Bn
Mar 31, 2024 6.02 Bn
Dec 31, 2023 5.37 Bn
Sep 30, 2023 54.00 Mn
Jun 30, 2023 53.00 Mn
Mar 31, 2023 53.00 Mn
Dec 31, 2022 4.94 Bn
Sep 30, 2022 223.00 Mn
Jun 30, 2022 210.00 Mn
Mar 31, 2022 210.00 Mn
Dec 31, 2021 5.54 Bn
API Access

Bristol Myers Squibb Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=BMY&period=max&api_key=YOUR_API_KEY